Piroxicam

Description

1. Product Overview

Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) widely utilized in pharmaceutical manufacturing for the treatment of pain, inflammation, and arthritis-related conditions. Its primary industrial use is as an active pharmaceutical ingredient (API) in tablets, capsules, topical formulations, and compounded medications. The key value proposition of Piroxicam lies in its proven efficacy, stable chemical profile, and compatibility with diverse pharmaceutical excipients, making it a reliable choice for large-scale drug production. Strategically, Piroxicam is critical in the global pain management and anti-inflammatory therapeutic segments, providing manufacturers with a high-demand, regulated API that supports both generic and branded pharmaceutical portfolios. Its consistent quality and regulatory compliance make it a dependable component in global healthcare supply chains.

2. Key Specifications & Technical Characteristics

• Chemical Composition:
  • C₁₅H₁₃N₃O₄S
  • Molecular Weight: 331.34 g/mol
• Purity Level / Grade:
  • Pharmaceutical grade (API)
  • Purity ≥ 99% (HPLC assay compliant)
  • Compliant with USP, EP, and BP standards
• Physical Characteristics:
  • Form: Crystalline powder
  • Color: White to off-white
  • Particle Size: 10–50 µm (batch-specific)
  • Density: 1.4–1.6 g/cm³
  • Odorless or faint characteristic odor
• Packaging Options:
  • Bulk drums with protective inner liners
  • Multi-layer bags with moisture barrier
  • ISO tank options for specialized liquid API solutions (if applicable)
• Shelf Life:
  • Typically 24–36 months under recommended storage conditions
  • Store in airtight containers, away from heat, moisture, and direct sunlight

3. Core Industrial Applications

Primary Industries:

• Pharmaceutical manufacturing
• Nutraceutical and compounded drug production
• Clinical research and formulation development

Operational Use Cases:

• Active ingredient in anti-inflammatory and analgesic formulations
• Component in fixed-dose combination therapies
• Input for tablet, capsule, topical, and injectable dosage forms

Performance & Cost Advantages:
Piroxicam offers superior chemical stability, high bioavailability, and predictable pharmacokinetics compared to alternative NSAIDs, enabling efficient formulation development and consistent therapeutic outcomes. Its cost-effectiveness, coupled with broad regulatory acceptance, makes it a preferred API in large-scale pharmaceutical production.

4. Competitive Advantages

• Quality Consistency: Strict batch-level QC testing ensures USP/EP/BP compliance
• Supply Reliability: Continuous production from validated facilities with high GMP standards
• Logistics Capability: Compliant shipping for pharmaceutical APIs, including hazardous material handling
• Price Competitiveness: Economically viable for bulk procurement in API-intensive production
• Sustainability & Compliance: Environmentally controlled manufacturing processes; waste and emission minimized
• Technical Documentation: COA, MSDS, GMP certification, regulatory dossiers available

Piroxicam is positioned as a strategic sourcing decision for pharmaceutical companies seeking a reliable, high-quality NSAID API to support both generic and branded drug pipelines.

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20MT
• Loading Capacity (MT per container): Approx. 20 MT per 20’ ISO container, dependent on packaging configuration and regulatory restrictions